These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21142537)

  • 1. Images in clinical medicine. Intravitreal triamcinolone for diabetic macular edema.
    Giuliari G
    N Engl J Med; 2010 Dec; 363(24):2351. PubMed ID: 21142537
    [No Abstract]   [Full Text] [Related]  

  • 2. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
    Grenga P; Lupo S; Domanico D; Vingolo EM
    Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema.
    Islam MS; Negi A; Vernon SA
    Eye (Lond); 2005 Dec; 19(12):1325-7. PubMed ID: 15578081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early effects of intravitreal triamcinolone on macular edema: mechanistic implication.
    Miyamoto N; Iossifov D; Metge F; Behar-Cohen F
    Ophthalmology; 2006 Nov; 113(11):2048-53. PubMed ID: 16935337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections.
    Lecleire-Collet A; Offret O; Gaucher D; Audren F; Haouchine B; Massin P
    Acta Ophthalmol Scand; 2007 Nov; 85(7):795-8. PubMed ID: 17459030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography.
    Kumar A; Sinha S
    Ophthalmology; 2008 Feb; 115(2):417-8; author reply 418. PubMed ID: 18243920
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
    Zamfir C
    Oftalmologia; 2009; 53(1):100-5. PubMed ID: 19569613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
    Ockrim ZK; Sivaprasad S; Falk S; Roghani S; Bunce C; Gregor Z; Hykin P
    Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.